We are live on ! Find out more
CPHI icon

China Pharma Holdings
CPHI

6 hedge funds and large institutions have $446K invested in China Pharma Holdings in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0.01% → 0.01% (+0%)

17% less capital invested

Capital invested by funds: $537K → $446K (-$91K)

33% less funds holding

Funds holding: 9 → 6 (-3)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
6
Holders Change
-3
Holders Change %
-33.33%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$24.4K
2
Renaissance Technologies
Renaissance Technologies
New York
+$20.7K
3
VF
Virtu Financial
New York
+$15.2K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$6K
2
UBS Group
UBS Group
Switzerland
-$3K
3
Goldman Sachs
Goldman Sachs
New York
-$2K

CPHI Hedge Fund Activity: Q3 2017 in Review

6 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q3 2017, worth a combined $446K — down 17% from $537K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CPHI and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Citadel Advisors, adding an estimated $24.4K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $6K sold.

  • 6 institutional investors held China Pharma Holdings (CPHI) as of Q3 2017, down from 9 in Q2 2017.
  • Funds reported $446K of China Pharma Holdings stock for Q3 2017, down 17% quarter-over-quarter.
  • 1 fund opened new China Pharma Holdings positions in Q3 2017 and 3 closed out, a net change of -2 holders.
  • The largest China Pharma Holdings buyer in Q3 2017 was Citadel Advisors, an estimated $24.4K added.
  • The largest China Pharma Holdings seller in Q3 2017 was Susquehanna International Group, an estimated $6K sold.

Based on aggregated 13F filings for Q3 2017.